Intezyne Closes Oversubscribed $10M Series A Financing to Drive Rapid Oncology Portfolio Development

By WebmasterOctober 6, 2017November 1st, 2024No Comments

Intezyne Closes Oversubscribed $10M Series A Financing to Drive Rapid Oncology Portfolio Development

Previous PostMEBIAS Discovery LLC Presents Pre-Clinical Data on MU Opioid Receptor Pain Compounds at ADDC
Next PostRelmada Therapeutics Announces $6.9 Million Private Placement